OGI News and Press, Organigram Holdings Inc. From 01/30/24

2024-01-30 13:15:35 ET More on U.S. MSOs Alan Brochstein On Rescheduling Overexcitement, MSOs, Canada And The Burden Of 280E Trulieve's Bold Tax Strategy: A Game Changer In The U.S. Cannabis Sector Trulieve Is Cheap But Perhaps Risky HHS document shows recomm...

2024-01-25 13:00:00 ET Summary Alan Brochstein thinks investors are overly excited about the recent cannabis rescheduling announcement, which is not significant news. The burden of 280E and other financial challenges, debt and income tax payable. What's right and wrong with Ca...

Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity ...

2024-01-21 11:02:27 ET Summary Trulieve's stock price is near a one-year high, outperforming other MSOs but not Tier 1 MSOs. Trulieve's growth is expected to be sluggish due to its dependence on the mature medical-only Florida cannabis market. Trulieve's valuation is relativel...

2024-01-20 10:56:39 ET Summary British American Tobacco has made aggressive investments in cannabis sending an irrational signal of the company panicking about the future of the cigarettes business. The stock crashed after announcing a massive write-down of US brands, again signal...

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024. This press relea...

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “ Shareholders ”) held virtually on January 18, 2024 (th...

Polydex Pharmaceuticals Inc (POLXF) is expected to report for quarter end 2023-10-31 RF Industries Ltd. (RFIL) is expected to report $-0.06 for Q4 2023 Northern Trust Corporation (NTRS) is expected to report $1.33 for Q4 2023 KeyCorp (KEY) is expected to report $0.22 for Q4 2023 S...

2024-01-16 13:13:37 ET More on Medmen Enterprises State attorneys general urge DEA to reschedule marijuana Financial information for Medmen Enterprises For further details see: Cannabis stocks rally as support builds for DEA rescheduling